December 8, 2019 – December 12, 2019
Recent Posts
- Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution
- VYLUMA ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR NVK002, ITS NOVEL INVESTIGATIONAL TREATMENT FOR PEDIATRIC MYOPIA
- VYLUMA TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
- VYLUMA ANNOUNCES POSITIVE RESULTS FROM PHASE 3 CHAMP STUDY OF NVK002 FOR TREATMENT OF MYOPIA PROGRESSION IN CHILDREN
- VYLUMA COMPLETES LAST PATIENT VISIT FOR PRIMARY ANALYSIS OF PIVOTAL PHASE III CHAMP STUDY EVALUATING NVK002 FOR THE TREATMENT OF MYOPIA PROGRESSION IN CHILDREN
Recent Comments